Targeting interleukin-1 in the treatment of rheumatoid arthritis.
Dayer
Jean-Michel
JM
Bresnihan
Barry
B
D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha